Delayed vs timely antiviral treatment initiation in adults hospitalized with influenza-associated pneumonia is linked to higher mortality risk.

The FDA has approved Dupixent as an add-on maintenance therapy for adults with inadequately controlled COPD and an eosinophilic phenotype.

Treatment with lumacaftor/ivacaftor in young children may lead to improvements and alter early cystic fibrosis disease progression.

In children developing asthma, levels of the immune mediator IL-10 are lower than normal by the time these children are 6 years of age.

HealthDay News — Measles cases in England are consistent with the waning of vaccine-induced immunity, according to a study published online Sept. 26 in The Lancet Public Health.

Reported ocular TB cases increased in the US between 1993 and 2019, despite decreasing TB cases, including extrapulmonary TB cases.

From 1999 to 2020, there was a decrease in menopausal hormone therapy (MHT) use among postmenopausal women. HealthDay News — From 1999 to 2020, there was a decrease in menopausal hormone therapy (MHT) ...

Lupus nephritis progression may be faster in patients with interstitial fibrosis/tubular atrophy (IFTA). Now a nomogram may predict it.

The FDA has updated the Fact Sheet for Health Care Providers for PrEP Pemgarda to include new data against circulating SARS-CoV-2 variants.

Lung ultrasound (LUS) is as effective as chest radiography (CXR) in diagnosing childhood community-acquired pneumonia, according to systematic review and meta-analysis findings published in Pediatric ...

Topline results were announced from a phase 3 trial evaluating rocatinlimab for the treatment of moderate to severe atopic dermatitis.

In adults with undiagnosed respiratory symptoms, dyspnea impact was worse in those with PRISm vs undiagnosed asthma or COPD.